loading...| Preferred Name | Fenoterol | |
| Synonyms |
|
|
| Definitions |
A short-acting sympathomimetic agent with bronchodilator activity. Fenoterol stimulates beta-2-adrenergic receptors in the lungs, thereby activating the enzyme adenylate cyclase that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cAMP). Increased cAMP concentrations relax bronchial smooth muscle, relieve bronchospasms, and reduce inflammatory cell mediator release, especially from mast cells. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C65659 |
|
| CAS_Registry |
13392-18-2 |
|
| CHEBI_ID |
CHEBI:149226 |
|
| Chemical_Formula |
C17H21NO4 |
|
| code |
C65659 |
|
| Contributing_Source |
FDA |
|
| definition |
A short-acting sympathomimetic agent with bronchodilator activity. Fenoterol stimulates beta-2-adrenergic receptors in the lungs, thereby activating the enzyme adenylate cyclase that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cAMP). Increased cAMP concentrations relax bronchial smooth muscle, relieve bronchospasms, and reduce inflammatory cell mediator release, especially from mast cells. |
|
| FDA_UNII_Code |
22M9P70OQ9 |
|
| Has_Salt_Form | ||
| in_subset | ||
| label |
Fenoterol |
|
| Legacy Concept Name |
Fenoterol |
|
| Preferred_Name |
Fenoterol |
|
| prefixIRI |
NCIT:C65659 |
|
| prefLabel |
Fenoterol |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0015840 |
|
| subClassOf |